High-speed scanless entire bandwidth mid-infrared chemical imaging

Mid-infrared spectroscopy probes molecular vibrations to identify chemical species and functional groups. Therefore, mid-infrared hyperspectral imaging is one of the most powerful and promising candidates for chemical imaging using optical methods. Yet high-speed and entire bandwidth mid-infrared hyperspectral imaging has not been realized. Here we report a mid-infrared hyperspectral chemical imaging technique that uses chirped pulse upconversion of sub-cycle pulses at the image plane. This technique offers a lateral resolution of 15 $\mu$m, and the field of view is adjustable between 800 $\mu$m $\times$ 600 $\mu$m to 12 mm $\times$ 9 mm. The hyperspectral imaging produces a 640 $\times$ 480 pixel image in 8 s, which covers a spectral range of 640-3015 cm$^{-1}$, comprising 1069 wavelength points and offering a wavenumber resolution of 2.6-3.7 cm$^{-1}$. For discrete frequency mid-infrared imaging, the measurement speed reaches a frame rate of 5 kHz, the repetition rate of the laser. As a demonstration, we effectively identified and mapped different components in a microfluidic device, plant cell, and mouse embryo section. The great capacity and latent force of this technique in chemical imaging promise to be applied to many fields such as chemical analysis, biology, and medicine.Comment: 22 pages, 10 figure

The sixth Painleve equation arising from D_4^{(1)} hierarchy

The sixth Painleve equation arises from a Drinfel'd-Sokolov hierarchy associated with the affine Lie algebra of type D_4 by similarity reduction.Comment: 14 page

Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy

AbstractObjectivesWe investigated the utility of the peak negative myocardial velocity gradient (MVG) derived from tissue Doppler imaging (TDI) for evaluation of diastolic dysfunction in patients with hypertrophic cardiomyopathy (HCM).BackgroundHypertrophic cardiomyopathy is characterized by impaired diastolic function with abnormal stiffness and prolonged relaxation. However, it remains difficult to evaluate these defects noninvasively.MethodsBoth TDI and conventional echocardiography were performed in 36 patients with HCM and in 47 control subjects. Left ventricular (LV) pressure was measured simultaneously in all HCM patients and in 26 controls.ResultsThe peak negative MVG occurred soon after the isovolumic relaxation period during the initial phase of rapid filling (auxotonic relaxation). It was significantly smaller in HCM patients than in control subjects (2.32 ± 0.52/s vs. 4.82 ± 1.15/s, p < 0.0001); the cutoff value for differentiation between all HCM patients and 47 normal individuals was determined as 3.2/s. Both the left ventricular end-diastolic pressure (LVEDP) (19.6 ± 6.1 mm Hg vs. 6.5 ± 1.7 mm Hg, p < 0.0001) and the time constant of LV pressure decay during isovolumic diastole (tau) (44.0 ± 6.7 ms vs. 32.1 ± 5.5 ms, p < 0.0001) were increased in HCM patients compared with controls. The peak negative MVG was negatively correlated with both LVEDP (r= −0.75, p < 0.0001) and tau (r= −0.58, p < 0.0001).ConclusionsA reduced peak negative MVG reflects both prolonged relaxation and elevated LVEDP. The peak negative MVG might thus provide a noninvasive index of diastolic function, yielding unique information about auxotonic relaxation in patients with HCM

Quality of life, depression, and productivity of city government employees in Japan : a comparison study using the Athens insomnia scale and insomnia severity index

Background:Insomnia has a high prevalence in modern society. Various tools have been developed to assess insomnia. We performed a direct comparison between the Insomnia Severity Index (ISI) and the Athens Insomnia Scale (AIS) in a Japanese population.Methods:A cross-sectional questionnaire-based study was conducted in September 2017 as part of the Night in Japan Home Sleep Monitoring Study. In addition to insomnia, assessed using the AIS and ISI, depression, sleepiness, quality of life, and work performance were assessed using the Patient Health Questionnaire (PHQ)-9, a Japanese version of the Epworth Sleepiness Scale, the Short Form-8 Health Survey Questionnaire (SF-8), and the World Health Organization Health and Work Performance Questionnaire, respectively. Receiver operating characteristic (ROC) curves were constructed to compare the outcomes of the AIS and the ISI.Results:A total of 1685 (81.9%) of all eligible employees were enrolled. The total scores of the AIS and ISI had a Pearson correlation coefficient (r) of 0.80 (p < 0.01). The area under the ROC curve for the AIS and ISI for the detection of depression (PHQ-9 ≥ 10) was 0.89 and 0.86, respectively. The prevalence of clinical insomnia (ISI ≥ 15) and definite insomnia (AIS ≥ 10) were 6.5 and 10.8%, respectively. Both the AIS and ISI showed a weak negative correlation with the physical component summary score of the SF-8 (r = − 0.37, p < 0.01 and r = − 0.32, p < 0.01, respectively) and absolute presenteeism (r = − 0.32, p < 0.01 and r = − 0.28, p < 0.01, respectively) and a moderate negative correlation with the mental component summary score of the SF-8 (r = − 0.53, p < 0.01 and r = − 0.43, p < 0.01, respectively).Conclusions:A strong positive correlation was found between the total scores of the AIS and ISI. Both the AIS and ISI were found to be associated with low physical and mental quality of life, depression, and productivity loss at work. Moreover, they had a moderate accuracy for detecting depression. Both the AIS and ISI may serve as useful screening tools for both insomnia and depression in the Japanese working population.Trial registration:UMIN-CTR (UMIN000028675, registered on 2017/8/15) and ClinicalTrials.gov (NCT03276585, registered on 2017/9/3)